32 related articles for article (PubMed ID: 22820083)
1. Infrequent hypermethylation of the PTEN gene in Korean non-small-cell lung cancers.
Kim DS; Lee SM; Yoon GS; Choi JE; Park JY
Cancer Sci; 2010 Feb; 101(2):568-72. PubMed ID: 20175786
[TBL] [Abstract][Full Text] [Related]
2. Survival of Lung Cancer Patients Dependent on the LOH Status for
Fry EA; Niehans GE; Kratzke RA; Kai F; Inoue K
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33120969
[TBL] [Abstract][Full Text] [Related]
3. Transposon Mutagenesis Screen Identifies Potential Lung Cancer Drivers and CUL3 as a Tumor Suppressor.
Dorr C; Janik C; Weg M; Been RA; Bader J; Kang R; Ng B; Foran L; Landman SR; O'Sullivan MG; Steinbach M; Sarver AL; Silverstein KA; Largaespada DA; Starr TK
Mol Cancer Res; 2015 Aug; 13(8):1238-47. PubMed ID: 25995385
[TBL] [Abstract][Full Text] [Related]
4. Loss of CDKN2A at chromosome 9 has a poor clinical prognosis and promotes lung cancer progression.
Liu W; Zhuang C; Huang T; Yang S; Zhang M; Lin B; Jiang Y
Mol Genet Genomic Med; 2020 Dec; 8(12):e1521. PubMed ID: 33155773
[TBL] [Abstract][Full Text] [Related]
5. microRNA-664 enhances proliferation, migration and invasion of lung cancer cells.
Zhu X; Ju S; Yuan F; Chen G; Shu Y; Li C; Xu Y; Luo J; Xia L
Exp Ther Med; 2017 Jun; 13(6):3555-3562. PubMed ID: 28588679
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-17-5p induces drug resistance and invasion of ovarian carcinoma cells by targeting PTEN signaling.
Fang Y; Xu C; Fu Y
J Biol Res (Thessalon); 2015 Dec; 22():12. PubMed ID: 26500892
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations in quadruple malignancies of a patient with multiple sclerosis: their role in malignancy development and response to therapy.
Milosevic Z; Tanic N; Bankovic J; Stankovic T; Buta M; Lavrnic D; Milovanovic Z; Pupic G; Stojkovic S; Milinkovic V; Ito Y; Dzodic R
Int J Clin Exp Pathol; 2014; 7(4):1826-33. PubMed ID: 24817989
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of epigenetic silencing of p16 gene in NSCLC patients: a systematic review and meta-analysis.
Lou-Qian Z; Rong Y; Ming L; Xin Y; Feng J; Lin X
PLoS One; 2013; 8(1):e54970. PubMed ID: 23372805
[TBL] [Abstract][Full Text] [Related]
10. Concurrent alteration of p16 and PTEN tumor suppressor genes could be considered as potential molecular marker for specific subgroups of NSCLC patients.
Andjelkovic T; Bankovic J; Milosevic Z; Stojsic J; Milinkovic V; Pesic M; Ruzdijic S; Tanic N
Cancer Biomark; 2011-2012; 10(6):277-86. PubMed ID: 22820083
[TBL] [Abstract][Full Text] [Related]
11. Comparative analyses of individual and multiple alterations of p53, PTEN and p16 in non-small cell lung carcinoma, glioma and breast carcinoma samples.
Stankovic T; Milinkovic V; Bankovic J; Dinic J; Tanic N; Dramicanin T; Tanic N
Biomed Pharmacother; 2014 Jun; 68(5):521-6. PubMed ID: 24767865
[TBL] [Abstract][Full Text] [Related]
12. Coalterations of p53 and PTEN tumor suppressor genes in non-small cell lung carcinoma patients.
Andjelkovic T; Bankovic J; Stojsic J; Milinkovic V; Podolski-Renic A; Ruzdijic S; Tanic N
Transl Res; 2011 Jan; 157(1):19-28. PubMed ID: 21146147
[TBL] [Abstract][Full Text] [Related]
13. Association of CCND1 overexpression with KRAS and PTEN alterations in specific subtypes of non-small cell lung carcinoma and its influence on patients' outcome.
Dragoj M; Milosevic Z; Bankovic J; Dinic J; Pesic M; Tanic N; Stankovic T
Tumour Biol; 2015 Nov; 36(11):8773-80. PubMed ID: 26055143
[TBL] [Abstract][Full Text] [Related]
14. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
